I found this interesting in light of recent Pfizer/ alopecia news:
To better understand why anti-androgen therapy is an important new therapeutic target in fighting Covid 19, a few points must first be emphasized:
1. There are clear gender disparities in terms of COVID-19 severity:
*males with androgenic alopecia (hair loss, baldness) are at higher risk
*users of anabolic androgenic steroids for recreational purposes are at higher risk
*women with hyperandrogenic phenotypes (polycystic ovarian syndrome, hirsutism…) present with greater symptoms of COVID-19
*children (pre-puberty) are notably protected against more severe COVID-19
https://covid19criticalcare.com/new-i-mask-faqs/